Global Pediatric Drugs and Vaccines Market Insights Forecasts to 2033

• The Global Pediatric Drugs and Vaccines Market Size was Valued at USD 122.5 Billion in 2023
• The Market Size is Growing at a CAGR of 8.04% from 2023 to 2033
• The Worldwide Pediatric Drugs and Vaccines Market Size is Expected to Reach USD 265.5 Billion by 2033
• Asia-Pacific is expected to Grow the fastest during the forecast period.

The Global Pediatric Drugs and Vaccines Market Size is Anticipated to Exceed USD 265.5 Billion by 2033, Growing at a CAGR of 8.04% from 2023 to 2033.

Market Overview

Pediatric drugs and vaccines are the healthcare therapeutics that focus on the age group from birth to the end of adolescence including antibiotics, analgesics, respiratory, GI, and vaccinations. Pediatric drugs and vaccines are the medical supplies for pediatric drug therapy that are used for managing ailments in infants, children, adolescents, and young adults. The pediatric drug dosing is calculated based on the weight or surface area of the patient's body and the patient’s age. The variations in drug absorption, distribution, metabolism, and elimination are observed according to the body's surface area and age. Pediatric vaccines are used for preventative treatment regimes in the pediatric population. It aids in stimulating the immunological response within the pediatric patient's body, thus vaccines are the protective shield against harmful viruses like smallpox, polio, and diphtheria. The inactive part of antigen is present in the vaccine formulation that is responsible for triggering an immune response inside the body ultimately leading to produce antibodies to fight against the viruses. Vaccination is a crucial preventative regime for preventing serious diseases and improving health globally. To protect children from illnesses including measles, mumps, rubella, diphtheria, pertussis, tetanus, polio, hepatitis, influenza, and more, vaccinations are frequently given during infancy and childhood.  

Report Coverage

This research report categorizes the market for the global pediatric drugs and vaccines market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global pediatric drugs and vaccines market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global pediatric drugs and vaccines market.

Driving Factors

The rising pediatric population surged for the market demand of pediatric drugs and vaccines. The growing prevalence of infectious diseases such as diphtheria, influenza, tetanus, pertussis, etc. in children drives the market growth. In addition, rising occurrences of various conditions like asthma, anorexia, cancer, birth deformities, growth deficits, juvenile diabetes, and attention deficit hyperactivity in children encourage raising spending on R&D for the development of pediatric mediations that ultimately lead to market growth in the near future. Furthermore, the rising awareness about the children’s healthcare needs growing the market demand.

Restraining Factors

Lack of accessibility due to lack of awareness and inadequate healthcare infrastructure which ultimately deprives the market of pediatric drugs and vaccines. The high cost of pediatric vaccines difficult to afford for low-income parents thus decreasing number of vaccination among the pediatric patients leads to restrain the market.

Market Segmentation

The global pediatric drugs and vaccines market share is classified into technology, drug indication, and distribution channel.

• The conjugate segment is expected to hold the largest share of the global pediatric drugs and vaccines market during the forecast period.    

Based on the technology, the global pediatric drugs and vaccines market is categorized into live attenuated, inactivated, subunit, toxoid, conjugate, and others. Among these, the conjugate segment is expected to hold the largest share of the global pediatric drugs and vaccines market during the forecast period. The growing cases of pneumococcal and meningococcal diseases among the pediatric population, increasing the need for conjugate vaccines. For instance, the pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine (PCV23) are the conjugate vaccines for the most common pneumococcal infections.

• The infectious diseases segment is expected to hold the largest share of the global pediatric drugs and vaccines market during the forecast period.    

Based on the drug indication, the global pediatric drugs and vaccines market is categorized into infectious disease, cancer, allergy and respiratory, nervous system disorders, cardiovascular disease, diabetes, and others. Among these, the infectious disease segment is expected to hold the largest share of the global pediatric drugs and vaccines market during the forecast period. The growing spread of viruses like MERS, Corona, and Plague, is increasing the market demand for pediatric drugs and vaccines for preventing infectious diseases among the pediatric population. Other bacterial infections include salmonella, pneumonia, Clostridium difficile (C. diff) and methicillin-resistant staphylococcus aureus (MRSA). Malaria, tapeworm, bed bugs and lice are the parasitic infections.

• The hospital pharmacy segment is expected to hold a significant share of the global pediatric drugs and vaccines market during the forecast period.

Based on the distribution channel, the global pediatric drugs and vaccines market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. Among these, the hospital pharmacy segment is expected to hold a significant share of the global pediatric drugs and vaccines market during the forecast period. Hospitals are primary healthcare centers for the treatment of pediatrics thus hospital pharmacy is considered to be crucial points for accessing pediatric drugs. Hospital pharmacies manage and dispense specialized pediatric formulations, ensuring accurate dosing and safety.  Additionally, collaborations between pharmaceutical companies and hospitals strengthens the influence of hospital pharmacies in the pediatric drug market.

Regional Segment Analysis of the global pediatric drugs and vaccines Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global pediatric drugs and vaccines market over the predicted timeframe.

North America is projected to hold the largest share of the global pediatric drugs and vaccines market over the forecast period. The rising population of children and increasing treatment option for pediatric diseases. The high healthcare spendings for treatment of pediatric diseases and ease of accessibility to advanced pediatric disease therapeutics due to advanced technology, and R&D, rising demand for preventive medical care leads to propel the market growth. Awareness regarding vaccine programs for pediatric for the prevention of diseases in the region is also responsible for market growth.

Asia-Pacific is expected to grow at the fastest CAGR growth of the global pediatric drugs and vaccines market during the forecast period. The rising awareness regarding the pediatric drugs and vaccines regime likely to grow the market. The ease of accessibility to advanced pediatric drug and vaccines, increasing disposable income, and developing healthcare systems are the other factors responsible for market growth of pediatric drugs and vaccines in the region.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global pediatric drugs and vaccines market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Novartis AG
• AstraZeneca
• Sanofi
• GlaxoSmithKline plc.
• Pfizer
• Merck & Co. Inc.
• Novo Nordisk A/S
• Eli Lilly and Company
• Serum Institute of India Pvt. Ltd.
• Panacea Biotec.
• Merck Sharp & Dohme Corp.
• Mitsubishi Tanabe Pharma Corporation
• Zydus Cadila
• Indian Immunologicals Ltd.
• Allergan Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent developments

• In July 2023, FDA approved a monoclonal antibody treatment to protect infants and young babies against RSV. Nirsevimab, the antibody marketed by AstraZeneca and Sanofi as Beyfortus are one shot vaccine given to children upto 24 months of age.

• In December 2021, Novartis Cosentyx received FDA approval for the treatment of children and adolescents with enthesitis-related arthritis and psoriatic arthritis.

• In October 2021, USFDA approved innovative treatment for pediatric patients with congenital Athymia, a rare immune disorder.

• In October 2020, FDA approved first treatment for COVID-19. The U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global pediatric drugs and vaccines market based on the below-mentioned segments:  

Global Pediatric Drugs and Vaccines Market, By Technology

• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Conjugate
• Others

Global Pediatric Drugs and Vaccines Market, By Drug Indication

• Infectious Disease
• Cancer
• Allergy and Respiratory
• Nervous System Disorders
• Cardiovascular Disease
• Diabetes
• Others

Global Pediatric drugs and vaccines Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Pediatric Drugs and Vaccines Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa